Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness
NCT03645850
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DEVICE:
Vismed gel Multi 0.3% eye drops
DEVICE:
Vismed Multi 0.18% eye drops
Sponsor
Horus Pharma